Valuation: Edwards Lifesciences Corporation

Market Cap 53.09B 46.52B 42.89B 39.63B 75.14B 5,064B 76.39B 512B 201B 2,494B 199B 195B 8,584B P/E 2026 *
32.9x
P/E 2027 * 28.2x
Enterprise Value 49.61B 43.47B 40.08B 37.03B 70.21B 4,732B 71.38B 479B 188B 2,331B 186B 182B 8,021B EV / Sales 2026 *
7.35x
EV / Sales 2027 * 6.48x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+0.96%
1 week-2.29%
Current month+1.93%
1 month+7.25%
3 months+18.42%
6 months+8.32%
Current year+8.16%
1 week 90.69
Extreme 90.69
96.29
1 month 83.17
Extreme 83.17
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
07-07Tax

Executive/Senior Manager

-377 0.0001%
06-30Fiscal year

Executive/Senior Manager

1,857 0.0003%
06-17Sell

Chief Executive Officer

-523 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%-2.29%+17.02%+0.62% 52.59B
+0.45%+0.69%+22.36%+1.97% 195B
-1.16%-4.51%-22.67%+19.55% 146B
-0.49%-0.82%-56.89%-15.05% 66.87B
+0.61%-1.06%-27.03%-30.23% 43.85B
+0.52%+2.75%+8.15%+13.46% 37.73B
-0.19%-0.75%+6.55%+42.23% 37.03B
-2.20%-2.75%-21.00%-5.88% 30.07B
0.00%-1.32%-15.42%-19.79% 29.43B
-1.84%+0.81%+90.10%+3.40% 29.32B
Average -0.20%-1.48%+0.12%+1.03% 66.76B
Weighted average by Cap. +0.07%-1.64%-1.40%+3.51%

Financials

2026 *2027 *
Net sales 6.75B 5.91B 5.45B 5.04B 9.55B 644B 9.71B 65.12B 25.54B 317B 25.33B 24.78B 1,091B 7.41B 6.49B 5.99B 5.53B 10.49B 707B 10.66B 71.51B 28.05B 348B 27.82B 27.22B 1,198B
Net income 1.62B 1.42B 1.31B 1.21B 2.3B 155B 2.34B 15.67B 6.15B 76.31B 6.1B 5.97B 263B 1.89B 1.66B 1.53B 1.41B 2.68B 180B 2.72B 18.25B 7.16B 88.84B 7.1B 6.95B 306B
Net Debt -3.48B -3.05B -2.81B -2.6B -4.93B -332B -5.01B -33.6B -13.18B -164B -13.07B -12.79B -563B -5.07B -4.44B -4.1B -3.79B -7.18B -484B -7.3B -48.95B -19.2B -238B -19.04B -18.63B -820B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
10/07/26 US$92.21 +0.96% 3,267,706
09/07/26 US$91.33 -2.47% 5,578,677
08/07/26 US$93.64 -1.24% 3,673,430
07/07/26 US$94.82 -0.38% 4,445,101
06/07/26 US$95.18 +0.86% 3,958,057
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
92.21USD
Average target price
97.92USD
Spread / Average Target
+6.20%

Quarterly revenue - Rate of surprise